abstract |
A pharmaceutical composition comprising a compound of formula (IA), formula (IV) or formula (V) wherein the variables are as defined herein and those useful for the treatment of a subject having a proliferative disorder such as cancer Disclose the product. The disclosed compounds and pharmaceutical compositions are also useful for the treatment of disorders that respond to Hsp70 induction and / or natural killer induction. |